Keywords
How to Cite
Abstract
Chronic Kidney Disease (CKD) is a progressive and irreversible decline in renal function lasting longer than three months. It represents a major global health burden due to its association with cardiovascular morbidity, end-stage renal disease (ESRD), and increased mortality. This study analyzes the pathogenesis, risk factors, diagnostic criteria, clinical manifestations, complications, and current treatment approaches of CKD.
References
1. KDIGO. (2022). Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
2. World Health Organization. (2023). Global Health Estimates Report.
3. International Society of Nephrology. (2023). Global Kidney Health Atlas.
4. Heerspink HJL, et al. (2020). Dapagliflozin in Patients with Chronic Kidney Disease. New England Journal of Medicine.
5. Brenner BM, et al. (2001). Effects of Losartan on Renal and Cardiovascular Outcomes. New England Journal of Medicine.
6. Levin A, et al. (2017). Kidney Disease: A Global Public Health Problem. The Lancet.
7. National Kidney Foundation. (2023). KDOQI Clinical Practice Guidelines.
This work is licensed under a Creative Commons Attribution 4.0 International License.